| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Seoyon Yang, Mathieu Boudier-Revéret, Yoo Jin Choo, Min Cheol Chan. Association between Chronic Pain and Alterations in the Mesolimbic Dopaminergic System. Brain sciences. vol 10. issue 10. 2020-11-03. PMID:33023226. |
studies on administration of dopaminergic drugs to control chronic pain, with a focus on increasing low dopamine levels in the mesolimbic system, show that it is effective in patients with parkinson's disease, restless legs syndrome, fibromyalgia, dry mouth syndrome, lumbar radicular pain, and chronic back pain. |
2020-11-03 |
2023-08-13 |
Not clear |
| Giuseppe Didato, Roberta Di Giacomo, Giuseppa Jolanda Rosa, Ambra Dominese, Marco de Curtis, Paola Lanter. Restless Legs Syndrome across the Lifespan: Symptoms, Pathophysiology, Management and Daily Life Impact of the Different Patterns of Disease Presentation. International journal of environmental research and public health. vol 17. issue 10. 2020-10-05. PMID:32456058. |
the diagnosis of restless legs syndrome can be challenging in some patients, especially children and elderly people, and an effective treatment might be far from being easy to achieve after some years of drug therapy, notably when dopaminergic agents are used. |
2020-10-05 |
2023-08-13 |
human |
| Nurten Uzun, Ayşegül Gündüz, Derya Karadeniz, Meral E Kizilta. Circadian Change in Blink Reflex Recovery in Restless Legs Syndrome. Noro psikiyatri arsivi. vol 53. issue 3. 2020-09-30. PMID:28373805. |
restless legs syndrome (rls) is associated with dysfunction of the dopaminergic systems in the pathways that specifically link the sensory input and motor output. |
2020-09-30 |
2023-08-13 |
Not clear |
| Ali Zeynal Abidin Tak, Mustafa Çelİk, Aysun Kalenderoğlu, Sadullah Sağlam, Yaşar Altun, Emre Gedİ. Evaluation of Optical Coherence Tomography Results and Cognitive Functions in Patients with Restless Legs Syndrome. Noro psikiyatri arsivi. vol 56. issue 4. 2020-09-30. PMID:31903030. |
the aim of this study was to evaluate whether retinal neural network was impaired and cognitive functions were disturbed in restless legs syndrome (rls) considering the hypothesis that there may be a dysfunction in dopaminergic pathways in rls like in parkinson's disease. |
2020-09-30 |
2023-08-13 |
Not clear |
| Thomas Derya Kocar, Hans-Peter Müller, Jan Kassube. Differential functional connectivity in thalamic and dopaminergic pathways in restless legs syndrome: a meta-analysis. Therapeutic advances in neurological disorders. vol 13. 2020-09-28. PMID:32821291. |
differential functional connectivity in thalamic and dopaminergic pathways in restless legs syndrome: a meta-analysis. |
2020-09-28 |
2023-08-13 |
Not clear |
| Shangru Lyu, Mark P DeAndrade, Stefan Mueller, Alexander Oksche, Arthur S Walters, Yuqing L. Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome. Behavioural brain research. vol 374. 2020-09-10. PMID:31376441. |
hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: implications for the restless legs syndrome. |
2020-09-10 |
2023-08-13 |
mouse |
| Min Seung Kim, Dong Gyu Park, Jung Han Yoo. Impaired endothelial function may predict treatment response in restless legs syndrome. Journal of neural transmission (Vienna, Austria : 1996). vol 126. issue 8. 2020-07-28. PMID:31218470. |
while dopaminergic dysfunction is believed to be a crucial role in restless legs syndrome (rls), changes in peripheral microvasculature system such as peripheral hypoxia and altered skin temperature, have been found. |
2020-07-28 |
2023-08-13 |
Not clear |
| Can Kocasarac, Yavuz Yigit, Lynn Marie Trotti, Sehnaz Basara. Ocular morphological changes in patients with restless legs syndrome analyzed by optical coherence tomography. Sleep medicine. vol 57. 2020-07-07. PMID:30878898. |
two leading hypotheses for restless legs syndrome (rls) pathophysiology are dopaminergic dysfunction and sympathetic overactivity. |
2020-07-07 |
2023-08-13 |
Not clear |
| Siraj Omar Wali, Bahaa Abaalkhail, Faris Alhejaili, S R Pandi-Peruma. Efficacy of vitamin D replacement therapy in restless legs syndrome: a randomized control trial. Sleep & breathing = Schlaf & Atmung. vol 23. issue 2. 2020-05-21. PMID:30430372. |
restless legs syndrome is a movement sleep disorder that may be linked to dopaminergic dysfunction and in which vitamin d may play a role. |
2020-05-21 |
2023-08-13 |
Not clear |
| Félix Javier Jiménez-Jiménez, Hortensia Alonso-Navarro, Elena García-Martín, José A G Agúnde. Neurochemical features of idiopathic restless legs syndrome. Sleep medicine reviews. vol 45. 2020-05-04. PMID:30965199. |
the most important traditional hypotheses of the pathogenesis of idiopathic restless legs syndrome (irls) involve dopaminergic dysfunction and iron deficiency. |
2020-05-04 |
2023-08-13 |
Not clear |
| Diego Garcia-Borreguero, Irene Cano-Pumarega, Celia Garcia Malo, Jose Antonio Cruz Velarde, Juan José Granizo, Vivian Wanne. Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment. Sleep medicine. vol 55. 2020-04-29. PMID:30772697. |
reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment. |
2020-04-29 |
2023-08-13 |
Not clear |
| Vivian Wanner, Celia Garcia Malo, Sofía Romero, Irene Cano-Pumarega, Diego García-Borreguer. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome. Advances in pharmacology (San Diego, Calif.). vol 84. 2019-12-18. PMID:31229171. |
non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome. |
2019-12-18 |
2023-08-13 |
Not clear |
| Claudia Trenkwalder, Walter Paulu. Pharmacological treatments of augmentation in restless legs syndrome patients. Advances in pharmacology (San Diego, Calif.). vol 84. 2019-12-18. PMID:31229175. |
augmentation, a treatment-induced paradoxical worsening of the symptoms of restless legs syndrome (rls) that is caused by long-term dopaminergic therapy, in particular with higher doses, remains the major challenge of rls treatment. |
2019-12-18 |
2023-08-13 |
Not clear |
| b' Antoni Cort\\xc3\\xa9s, Ver\\xc3\\xb2nica Casad\\xc3\\xb3-Anguera, Estefan\\xc3\\xada Moreno, Vicent Casad\\xc3\\xb. The heterotetrameric structure of the adenosine A Advances in pharmacology (San Diego, Calif.). vol 84. 2019-12-18. PMID:31229177.' |
the heterotetrameric structure of the adenosine a dopaminergic and purinergic signaling play a pivotal role in neurological diseases associated with motor symptoms, including parkinson's disease (pd), multiple sclerosis, amyotrophic lateral sclerosis, huntington disease, restless legs syndrome (rls), spinal cord injury (sci), and ataxias. |
2019-12-18 |
2023-08-13 |
Not clear |
| Hatice Kumru, Sergiu Albu, Joan Vidal, Manuela Barrio, Joan Santamari. Dopaminergic treatment of restless legs syndrome in spinal cord injury patients with neuropathic pain. Spinal cord series and cases. vol 2. 2019-11-20. PMID:28053765. |
dopaminergic treatment of restless legs syndrome in spinal cord injury patients with neuropathic pain. |
2019-11-20 |
2023-08-13 |
Not clear |
| Beatrice Heim, Marie-Theres Pertl, Ambra Stefani, Anna Heidbreder, Laura Zamarian, Elisabeth Brandauer, Bruno Averbeck, Margarete Delazer, Klaus Seppi, Birgit Högl, Werner Poewe, Atbin Djamshidia. Reflection impulsivity perceptual decision-making in patients with restless legs syndrome. Annals of clinical and translational neurology. vol 5. issue 3. 2019-11-20. PMID:29560376. |
the objective of this study was to investigate perceptual decision-making and reflection impulsivity in drug naïve patients with restless legs syndrome (rls) and patients with dopaminergic therapy. |
2019-11-20 |
2023-08-13 |
Not clear |
| K Pitarokoili, M Fels, A Kerasnoudis, L Tönges, R Gold, M-S Yoo. High-Resolution Nerve Ultrasound and Electrophysiological Findings in Restless Legs Syndrome. Journal of neuroimaging : official journal of the American Society of Neuroimaging. vol 28. issue 5. 2019-11-13. PMID:29749662. |
restless legs syndrome (rls) is a multifactorial network disorder of a sensorimotor system extending from dopaminergic and glutamatergic cerebral structures to the spinal neurons and peripheral nerves. |
2019-11-13 |
2023-08-13 |
Not clear |
| Pingping Ning, Fayun Hu, Baiyuan Yang, Qiuyan Shen, Quanzhen Zhao, Hongyan Huang, Ran An, Yalan Chen, Hui Wang, Xinglong Yang, Yanming X. Systematic review and meta-analysis of observational studies to understand the prevalence of restless legs syndrome in multiple sclerosis: an update. Sleep medicine. vol 50. 2019-11-04. PMID:30025277. |
multiple sclerosis (ms) is related to the demyelination of intracranial nerves at multiple sites, while restless legs syndrome (rls) appears to be caused by dysfunction of the dopaminergic system. |
2019-11-04 |
2023-08-13 |
Not clear |
| Sophia Stephanie Steinke, Claudia Trenkwalder, Johannes Zimmermann, Friederike Sixel-Döring, Maria-Lucia Muntea. Polysomnographic findings in restless legs syndrome (RLS) patients with severe augmentation. Sleep medicine. vol 48. 2019-10-14. PMID:29860190. |
augmentation can occur frequently in restless legs syndrome (rls) patients treated with dopaminergic agents. |
2019-10-14 |
2023-08-13 |
Not clear |
| Ana Marques, Michela Figorilli, Bruno Pereira, Philippe Derost, Berengere Debilly, Patricia Beudin, Tiphaine Vidal, Franck Durif, Maria Livia Fantin. Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study. Sleep medicine. vol 48. 2019-10-14. PMID:29913341. |
our objective is to determine whether restless legs syndrome (rls), that has been associated with more impulsive choices in general population regardless of dopaminergic therapy, could be associated with a specific psycho-behavioral profile and icds in pd. |
2019-10-14 |
2023-08-13 |
Not clear |